Acta Neurologica Scandinavica · 2008 · 15 citations · 33 references
Life SciencesNeurologyNeuroscienceImmunopathologyNeurochemistryNeuroimmunologyAstrocyte BiologyCerebral EdemaCerebrospinal Fluid BiomarkersCerebrovascular DiseaseNeuroinflammationReactive GliosisCerebrospinal Fluid AnalysisCerebrospinal Fluid SystemCystatin CImmunohistochemical BiomarkersImmunohistochemical MarkersMatrix MetalloproteinasesWhite Matter LesionsWhite Matter Pathology
OBJECTIVES: To study the involvement of cystatin C in the progression of ischemic white matter lesions (WMLs). MATERIALS AND METHODS: Cystatin C levels in the cerebrospinal fluid (CSF) of patients with cerebrovascular disease, and also in primary and established human neural cell cultures were investigated. For pathologic analysis, cystatin C immunoreactivity was investigated in the white matter of patients with severe WMLs, mild WMLs or controls. RESULTS: Cystatin C levels in the CSF of patients with Fazekas WML grade 3 [14 with hypertension; W/HT(+) and nine without hypertension; W/HT(-)] were lower than those in 38 patients with grade 0-1 (P = 0.0022 and P < 0.0001 respectively). Immunohistochemical study showed that the cystatin C immunoreactivity was found in astrocytes, and the number of astrocytes in the white matter in the severe WML group was decreased when compared with that in controls (P = 0.0027) and in the mild WML group (P = 0.0024). In human neural cell cultures, treatments with thrombin, matrix metalloproteinases and interleukin 1 beta increased the expression of cystatin C mRNA in human astrocytes and hybrid neurons, but an enzyme-linked immunosorbent assay revealed that only thrombin significantly increased the production and secretion of cystatin C in astrocytes. CONCLUSIONS: These results suggest that low levels of CSF cystatin C in ischemic WMLs might be due to the decreased number of astrocytes that secrete cystatin C in response to the stimuli of proteases and inflammatory cytokines.
33
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Suzanne S. Mirra, Albert Heyman, Daniel W. McKeel et al. · Neurology · 1991 · 5.1K citations
Magnus Abrahamson, A. John Barrett, Guy S. Salvesen et al. · Journal of Biological Chemistry · 1986 · 507 citations · Full text
Prothrombin mRNA is expressed by cells of the nervous system
Melitta Dihanich, Matthew R. Kaser, Eva Reinhard et al. · Neuron · 1991 · 339 citations
Jorge Ghiso, O Jensson, Blas Frangione · Proceedings of the National Academy of Sciences · 1986 · 335 citations · Full text